[Therapy of plasma coagulation defects. II. Acquired coagulation disorders].
D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D007611:Aprotinin / Q000627:therapeutic use; D001778:Blood Coagulation Disorders / Q000209:etiology*; D001779:Blood Coagulation Factors; D005342:Fibrinolysis; D006801:Humans; D013917:Thrombin / Q000627:therapeutic use; D014511:Uremia / Q000209:etiology; D014812:Vitamin K / Q000627:therapeutic use; D014813:Vitamin K Deficiency / Q000175:diagnosis
D000933:Antifibrinolytic Agents; D001779:Blood Coagulation Factors; D014812:Vitamin K; D007611:Aprotinin; D013917:Thrombin
Die Therapie plasmatischer Gerinnungsdefekte. II. Erworbene Koagulopathien.